Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mitsubishi Chemical Life Sciences (MCLS) is a global leader in the development and manufacture of functional ingredients for the food, health, and pharmaceutical industries. As a core subsidiary of the Mitsubishi Chemical Group, the company utilizes advanced biotechnology, including fermentation and enzymatic synthesis, to produce high-purity nutritional components. Its diverse portfolio features key products such as Coenzyme Q10, HMB, and L-Cysteine, which are used to address indications ranging from cardiovascular health to muscle maintenance (sarcopenia). MCLS operates a robust international network with a significant presence in Japan, Europe, and North America, focusing on science-driven solutions to enhance human wellness. The company is recognized for its commitment to quality and innovation in the food as medicine sector, bridging the gap between traditional nutrition and therapeutic support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MCLS.